Abstract 2638: Sacituzumab Govitecan, combination with PARP inhibitor, Talazoparib, in metastatic triple-negative breast cancer (TNBC): Translational investigation
暂无分享，去创建一个
A. Niemierko | A. Bardia | D. Juric | L. Ellisen | S. Wander | B. Moy | J. Peppercorn | A. Partridge | S. Tolaney | Sheng Sun | H. Parsons | A. Nagayama | V. Attaya | D. Fitzgerald | V. Bossuyt | James T Coates | P.K. Ryan | Nayana Thimmiah | M. Shellock | Laura M. Spring | Brenda Lormil | Kelsey Pierce